US Stock MarketDetailed Quotes

ATOS Atossa Therapeutics

Watchlist

1.2900
+0.0100+0.78%

Close Nov 26 16:00 ET

1.3000
+0.0100+0.78%

Pre 08:48 ET

162.28MMarket Cap-6142P/E (TTM)

Atossa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Atossa Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Atossa Therapeutics Earnings Reports

Atossa Therapeutics | 8-K: Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 12 12:18 ET

Atossa Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 12 12:18 ET

Atossa Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12 09:10 ET

Atossa Therapeutics | 8-K: Atossa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 12 09:05 ET

Analyst Rating

Updated: Nov 13, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall